Editorial Board

        Editor-in-Chief

        GREGORY J. TSONGALIS, PhD, HCLD
        Professor, Department of Pathology andLaboratory Medicine, The Audrey andTheodore Geisel School of Medicine atDartmouth, Hanover, NH, USA; Vice Chairfor Research and Director, Laboratory forClinical Genomics and AdvancedTechnology (CGAT), Department ofPathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA

        Section Editors

        AHMAD N. ABOU TAYOUN, PhD, FACMG – Genetics
        Al Jalila Genomics Center, Al Jalila Children's Specialty Hospital, Center for Genomic Discovery, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
        HELEN FERNANDES, PhD - Infectious Disease and COVID-19
        Professor of Pathology & Cell Biology, Co-Director Genomic Oncology, Laboratory of Personalized Genomic Medicine, Columbia University Medical Center, New York, NY, USA
        ANDREA FERREIRA-GONZALEZ, PhD, HCLD(ABB), CC(ABB), FACB – Solid Tumors
        Professor and Chair Molecular Diagnostics Division, Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA
        MATTHEW LEBO, PhD, FACMG - Informatics
        Director, Laboratory for Molecular Medicine, Director, Bioinformatics, Mass General Brigham Personalized Medicine, Assistant Professor of Pathology, Brigham and Woman's Hospital and Harvard Medical School, Associate Member – Broad Institute, Cambridge, MA, USA
        ERIC Y. LOO, MD - Hematopathology
        Assistant Professor of Pathology & Laboratory Medicine, Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
        ANN M. MOYER, MD, PhD – Pharmacogenomics
        Associate Professor of Laboratory Medicine and Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA